Longs Drug Stores (LDG) Reports Mixed Q2 Earnings
Longs Drug Stores Corp. (NYSE: LDG) reports Q2 EPS of $0.78, ex-items, 2 cents better than the analyst estimate of $0.76. Revenues for the quarter were $1.33 billion, versus the consensus of $1.35 billion.
Notably, the company is being acquired by CVS/Caremark (NYSE: CVS).
Longs Drug Stores Corporation operates retail drug stores and provides pharmacy benefit management services in the United States.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
